Correlation Between Crinetics Pharmaceuticals and Cullinan Oncology
Can any of the company-specific risk be diversified away by investing in both Crinetics Pharmaceuticals and Cullinan Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Crinetics Pharmaceuticals and Cullinan Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Crinetics Pharmaceuticals and Cullinan Oncology LLC, you can compare the effects of market volatilities on Crinetics Pharmaceuticals and Cullinan Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Crinetics Pharmaceuticals with a short position of Cullinan Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Crinetics Pharmaceuticals and Cullinan Oncology.
Diversification Opportunities for Crinetics Pharmaceuticals and Cullinan Oncology
-0.36 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Crinetics and Cullinan is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Crinetics Pharmaceuticals and Cullinan Oncology LLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cullinan Oncology LLC and Crinetics Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Crinetics Pharmaceuticals are associated (or correlated) with Cullinan Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cullinan Oncology LLC has no effect on the direction of Crinetics Pharmaceuticals i.e., Crinetics Pharmaceuticals and Cullinan Oncology go up and down completely randomly.
Pair Corralation between Crinetics Pharmaceuticals and Cullinan Oncology
Given the investment horizon of 90 days Crinetics Pharmaceuticals is expected to generate 0.57 times more return on investment than Cullinan Oncology. However, Crinetics Pharmaceuticals is 1.74 times less risky than Cullinan Oncology. It trades about -0.03 of its potential returns per unit of risk. Cullinan Oncology LLC is currently generating about -0.25 per unit of risk. If you would invest 5,840 in Crinetics Pharmaceuticals on August 24, 2024 and sell it today you would lose (137.00) from holding Crinetics Pharmaceuticals or give up 2.35% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Crinetics Pharmaceuticals vs. Cullinan Oncology LLC
Performance |
| Timeline |
| Crinetics Pharmaceuticals |
| Cullinan Oncology LLC |
Crinetics Pharmaceuticals and Cullinan Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Crinetics Pharmaceuticals and Cullinan Oncology
The main advantage of trading using opposite Crinetics Pharmaceuticals and Cullinan Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Crinetics Pharmaceuticals position performs unexpectedly, Cullinan Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cullinan Oncology will offset losses from the drop in Cullinan Oncology's long position.| Crinetics Pharmaceuticals vs. Viridian Therapeutics | Crinetics Pharmaceuticals vs. Cytokinetics | Crinetics Pharmaceuticals vs. Structure Therapeutics American | Crinetics Pharmaceuticals vs. Passage Bio |
| Cullinan Oncology vs. Lyra Therapeutics | Cullinan Oncology vs. Hookipa Pharma | Cullinan Oncology vs. Cingulate Warrants | Cullinan Oncology vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Complementary Tools
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |